All News
Filter News
Found 808,448 articles
-
Tesaro Attempts to Squash Partner Myriad Genetics’ Contrary Press Release Over Niraparib
10/14/2016
-
EMA Committee Conditionally Approves AbbVie's Leukaemia Drug VENCLYXTO
10/14/2016
-
If You Had to Choose, bluebird bio vs. Inovio Pharma
10/14/2016
-
Bristol-Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) for the Treatment of Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant and Treatment With Brentuximab Vedotin
10/14/2016
-
11 Health Innovations That Could Save 6 Million Lives By 2030
10/14/2016
-
Regeneron Bets $315 Million on Ocular Therapeutix for an Upgraded Form of Eylea
10/14/2016
-
Intercept Pharma Gains Positive CHMP Opinion for Ocaliva
10/14/2016
-
3 Biotechs Expecting News this Week That Can Affect Their Stocks
10/14/2016
-
Clementia Announces Top-line Results from Phase 2 Trial of Palovarotene for Treatment of Patients with Fibrodysplasia Ossificans Progressiva
10/14/2016
-
Fasting Could Prevent Aging And Transform Your Body, But It Goes Against Everything We Think Of As Healthy, Royal Infirmary Of Dundee Study
10/14/2016
-
Drug Pricing Woes Hit Vertex as One Mom Travels to Boston to Take on CEO
10/14/2016
-
Eisai Inc. Release: Preliminary Results From Lenvatinib + Pembrolizumab Phase 1b Clinical Study In Select Solid Tumors Presented At ESMO 2016
10/14/2016
-
Bristol-Myers Squibb Receives Positive CHMP Opinion For Opdivo(Nivolumab) For The Treatment Of Adult Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant And Treatment With Brentuximab Vedotin
10/14/2016
-
These Are The Top 10 Life Sciences VC Deals In Q3
10/14/2016
-
Check Out These 20 Boston Area Biotechs That Spent Less on R&D This Year
10/14/2016
-
Google's Verily to Not Only Tackle Diabetes, But Zika as Well
10/14/2016
-
3 Healthcare Giants Are All Trying to Take a Bite Out of AbbVie's Humira Domination
10/14/2016
-
TetraPhase Doses First Patient In IGNITE4 Phase 3 Clinical Trial Of Eravacycline In cIAI
10/14/2016
-
AdAlta Pty Ltd. Update On Orphan Drug Designation Application For Lead Drug Targeting Idiopathic Pulmonary Fibrosis
10/14/2016
-
Creative Bioarray Added Endothelial Cells
10/14/2016